Literature DB >> 15350945

Adjuvant therapy for pancreatic cancer: current status and future directions.

Henry Q Xiong1, James L Abbruzzese.   

Abstract

This article summarizes the important past and ongoing adjuvant therapy trials for pancreatic cancer. The recent developments in the fields of radiosensitization, chemotherapy, and molecular-targeted therapy are outlined. Finally, the future study strategies for adjuvant therapy trials are discussed.

Entities:  

Mesh：

Year:  2004        PMID： 15350945     DOI： 10.1016/j.soc.2004.06.010

Source DB:  PubMed          Journal:  Surg Oncol Clin N Am        ISSN： 1055-3207            Impact factor:   3.495


  1 in total

1.  Calorie restriction decreases murine and human pancreatic tumor cell growth, nuclear factor-κB activation, and inflammation-related gene expression in an insulin-like growth factor-1-dependent manner.

Authors:  Alison E Harvey; Laura M Lashinger; Drew Hays; Lauren M Harrison; Kimberly Lewis; Susan M Fischer; Stephen D Hursting
Journal:  PLoS One       Date:  2014-05-07       Impact factor: 3.240
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.